InspireMD Other Current Liab vs Common Stock Analysis
| NSPR Stock | USD 2.30 0.08 3.36% |
InspireMD financial indicator trend analysis is infinitely more than just investigating InspireMD recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InspireMD is a good investment. Please check the relationship between InspireMD Other Current Liab and its Common Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.
Other Current Liab vs Common Stock
Other Current Liab vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InspireMD Other Current Liab account and Common Stock. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between InspireMD's Other Current Liab and Common Stock is -0.08. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Common Stock in the same time period over historical financial statements of InspireMD, assuming nothing else is changed. The correlation between historical values of InspireMD's Other Current Liab and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of InspireMD are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Other Current Liab i.e., InspireMD's Other Current Liab and Common Stock go up and down completely randomly.
Correlation Coefficient | -0.08 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Other Current Liab
Common Stock
Most indicators from InspireMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Tax Provision is relatively stable compared to the past year. As of 05/18/2024, Sales General And Administrative To Revenue is likely to grow to 2.31, while Issuance Of Capital Stock is likely to drop slightly above 27.4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 3.7M | 4.1M | 4.4M | 3.1M | Research Development | 5.2M | 7.8M | 8.0M | 4.3M |
InspireMD fundamental ratios Correlations
Click cells to compare fundamentals
InspireMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InspireMD fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 9.9M | 17.8M | 39.7M | 24.7M | 47.6M | 50.0M | |
| Other Current Liab | 2.1M | 3.1M | 3.0M | 4.0M | 4.5M | 2.7M | |
| Total Current Liabilities | 3.1M | 3.7M | 4.3M | 5.1M | 6.0M | 4.2M | |
| Total Stockholder Equity | 5.4M | 12.2M | 33.5M | 17.4M | 39.5M | 41.5M | |
| Net Debt | (4.9M) | (11.6M) | (10.8M) | (3.0M) | (9.6M) | (9.2M) | |
| Retained Earnings | (157.6M) | (168.2M) | (183.1M) | (201.6M) | (221.5M) | (210.4M) | |
| Cash | 5.5M | 12.6M | 12.0M | 4.6M | 9.6M | 7.6M | |
| Cash And Short Term Investments | 5.5M | 12.6M | 34.0M | 17.8M | 39.0M | 41.0M | |
| Common Stock Shares Outstanding | 139.3K | 1.5M | 7.3M | 7.9M | 24.3M | 25.5M | |
| Liabilities And Stockholders Equity | 9.9M | 17.8M | 39.7M | 24.7M | 47.6M | 50.0M | |
| Other Stockholder Equity | 163.0M | 180.3M | 216.6M | 219.0M | 261M | 138.1M | |
| Total Liab | 4.5M | 5.6M | 6.2M | 7.3M | 8.1M | 6.9M | |
| Total Current Assets | 7.8M | 15.3M | 37.1M | 21.3M | 44.2M | 46.4M | |
| Non Current Assets Total | 2.1M | 2.4M | 2.6M | 3.3M | 3.5M | 2.0M | |
| Non Currrent Assets Other | 586K | 725K | 905K | 856K | 951K | 654.2K | |
| Net Receivables | 973K | 945K | 1.4M | 1.2M | 1.8M | 1.0M | |
| Non Current Liabilities Total | 1.4M | 1.9M | 1.8M | 2.2M | 2.1M | 2.1M | |
| Inventory | 1.2M | 1.4M | 1.1M | 1.6M | 2.1M | 1.2M | |
| Property Plant And Equipment Gross | 421K | 1.5M | 1.7M | 2.5M | 4.6M | 4.8M | |
| Other Liab | 729K | 910K | 1.1M | 995K | 1.1M | 738.6K | |
| Property Plant And Equipment Net | 421K | 1.5M | 1.7M | 2.5M | 2.5M | 2.7M | |
| Accounts Payable | 646K | 236K | 893K | 659K | 939K | 570.7K | |
| Other Assets | 586K | 725K | 905K | 856K | 984.4K | 506K | |
| Retained Earnings Total Equity | (140.4M) | (147.6M) | (157.6M) | (168.2M) | (151.4M) | (158.9M) | |
| Other Current Assets | 87K | 334K | 522K | 15.1M | 3.0M | 1.6M | |
| Property Plant Equipment | 547K | 448K | 1.7M | 2.5M | 2.8M | 3.0M | |
| Net Tangible Assets | 5.4M | 12.2M | 33.5M | 17.4M | 20.0M | 21.0M | |
| Capital Surpluse | 143.1M | 156.4M | 163.0M | 180.3M | 207.4M | 157.7M | |
| Non Current Liabilities Other | 624K | 605K | 1.4M | 1.9M | 2.2M | 2.3M | |
| Net Invested Capital | 5.4M | 12.2M | 33.5M | 17.4M | 39.5M | 41.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.